Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Pfizer (NY:PFE)

25.23 -1.20 (-4.56%)
Streaming Delayed Price Updated: 11:39 AM EST, Dec 16, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Pfizer

< Previous 1 2
...
24 25 26 27 28 29 30 31 32
...
99 100 Next >
News headline image
OPKO Health (OPK) Q2 2025 Earnings Call Transcript ↗
Via The Motley Fool
Topics Earnings
News headline image
This 7% Yielding Stock Just Raised Its Profit Forecast. Is It Time to Buy? ↗
Meeting its dividend commitment this year should be a breeze, but the path ahead is much harder to predict. 
Via The Motley Fool
Topics Government Intellectual Property World Trade
News headline image
Is It Time to Buy Biotech Stocks? ↗
A surge in private market investment has investors wondering: Is it time to bet bigger on biotech? 
Via The Motley Fool
News headline image
Wednesday's session: most active stock in the S&P500 index ↗
Let's have a look at what is happening on the US markets on Wednesday. Below you can find the most active S&P500 stocks in today's session. 
Via Chartmill
News headline image
Trump Tweets Trigger Stock Swings For Tesla, Boeing, Pfizer—And An Insider Trading Inquiry ↗
Trump tweets trigger major stock swings for companies like Tesla, Boeing, Pfizer. Democrats demand an investigation. 
Via Benzinga
Topics Government
News headline image
1 Reason to Buy Pfizer (PFE) Stock ↗
How does $740 in annual income sound? 
Via The Motley Fool
Topics Intellectual Property
News headline image
RFK Jr. Halts $500 Million In mRNA Vaccine Projects Backed By Pfizer, Moderna: 'We're Prioritizing Safer, Broader Strategies' ↗
The Department of Health and Human Services will cancel 22 vaccine development projects totaling $500 million. 
Via Benzinga
News headline image
Stock Market Today: US Futures Edge Higher As Investors Await Earnings From McDonald's, Uber And Walt Disney ↗
US stock futures rose on Wed. after falling on Thurs. Trump threatened tariffs on imported pharma up to 250%. Bond yields down & Fed may cut rates. 
Via Benzinga
Topics Economy Government World Trade
News headline image
Novo Nordisk Edges Up Premarket As Q2 Wegovy Sales Defy Copycat Threats: Retail Stays Bullish Amid Tariff Pressure ↗
The results follow Novo’s worst weekly decline in its history after the company slashed its full-year guidance. 
Via Stocktwits
Topics Government World Trade
News headline image
Trump Threatens Pharma With Potential 250% Tariffs In 18 Months: 'We Want Pharmaceuticals Made In Our Country' ↗
President Donald Trump has indicated the possibility of imposing tariffs on imported pharmaceuticals that could rise up to 250%, indicating the highest rate he has proposed so far. 
Via Benzinga
Topics Government World Trade
News headline image
Nasdaq Dips Over 100 Points Following Economic Data: Investor Sentiment Declines, Fear & Greed Index Moves To 'Neutral' Zone ↗
 
Via Benzinga
News headline image
Market Monitor News August 06 BMO - Wall Street Slides as Services Sector Falters, but Palantir Rockets Past Expectations ↗
A weaker-than-expected ISM services report reignited fears of a slowing U.S. economy, dragging major indices into the red. 
Via Chartmill
Topics Economy
Moderna, Pfizer, Sanofi In Focus As US Winds Down mRNA Vaccine Plans; Retail Turns Bearish On AstraZeneca ↗
Via Stocktwits
News headline image
Why Shares of Pfizer Soared Today ↗
The large pharmaceutical company reported strong second-quarter earnings results. 
Via The Motley Fool
Topics Government World Trade
News headline image
Will Amgen, Already Above Its 50-Day Line, Break Out On This Earnings News? ↗
Amgen crushed second-quarter forecasts late Tuesday. The news could push Amgen stock into a breakout. 
Via Investor's Business Daily
News headline image
Top S&P500 movers in Tuesday's session ↗
Stay updated with the movement of S&P500 stocks in today's session. Discover which S&P500 stocks are making waves on Tuesday. 
Via Chartmill
Pfizer In Talks With Trump Administration Regarding Lower Drug Prices And Tariffs, Says CEO: Stock Rallies On Improved Full-Year Guidance, Upbeat Q2 Report ↗
Via Stocktwits
Topics Government
News headline image
Looking for the most active stocks in the S&P500 index on Tuesday? ↗
Stay informed about the most active S&P500 stocks in today's session as we take a closer look at what's happening on the US markets on Tuesday. Discover the stocks that are generating the highest... 
Via Chartmill
Palantir, Pfizer, Hims & Hers, Intel, UnitedHealth: Stocks Making The Biggest Moves Today ↗
Via Stocktwits
News headline image
Stocks Drop As Trump Tariffs Fuel Inflation, Palantir Hits $400 Billion Value: What's Moving Market Tuesday? ↗
Stocks slipped Tuesday as fresh economic data reignited stagflation fears on Wall Street, overshadowing a blowout quarter from Palantir Technologies Inc. 
Via Benzinga
Topics Economy Government
News headline image
TSMC Stock Slips On Suspected Trade Secrets Theft ↗
TSMC stock fall on news of suspected trade secrets theft at the semiconductor manufacturing powerhouse, a major player in the AI chip market. 
Via Investor's Business Daily
Topics Artificial Intelligence
News headline image
Which S&P500 stocks are moving on Tuesday? ↗
Join us in exploring the top gainers and losers within the S&P500 index in the middle of the day on Tuesday as we examine the latest happenings in today's session. 
Via Chartmill
News headline image
What's going on in today's session: S&P500 gap up and gap down stocks ↗
Wondering what's happening in today's session regarding gap up and gap down stocks? Explore the S&P500 index on Tuesday to uncover the stocks that are gapping in the S&P500 index. 
Via Chartmill
News headline image
Pfizer Beats Expectations In Q2 2025, Raises EPS Guidance ↗
Pfizer's second-quarter 2025 results exceeded expectations with a 10% revenue growth and an adjusted EPS of $0.78. 
Via Talk Markets
News headline image
Pfizer Cost-Cut Initiatives More Than Offset Tariffs Impact, Raises Outlook ↗
Pfizer posts better-than-expected Q2 earnings and sales, raises 2025 EPS outlook, and outlines $7.7 billion in cost-saving initiatives through 2027. 
Via Benzinga
News headline image
Dow Surges Over 100 Points; Pfizer Earnings Top Views ↗
 
Via Benzinga
Topics Stocks
News headline image
Pfizer Smashes Earnings Forecasts And Raises Outlook; Shares Jump ↗
Shares advanced within striking distance of their 50-day line. 
Via Investor's Business Daily
News headline image
Zoetis (NYSE:ZTS) Posts Better-Than-Expected Sales In Q2, Stock Soars
Animal health company Zoetis (NYSE:ZTS) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 4.2% year on year to $2.46 billion. The company expects the full year’s revenue... 
Via StockStory
News headline image
If You'd Invested $1,000 in PFE 5 Years Ago, Here's How Much You'd Have Today ↗
It's been a roller-coaster ride for Pfizer's stock over the past half-decade. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Pfizer (NYSE:PFE) Reports Upbeat Q2
Global pharmaceutical company Pfizer (NYSE:PFE) announced better-than-expected revenue in Q2 CY2025, with sales up 10.3% year on year to $14.65 billion. The company expects the full year’s revenue to... 
Via StockStory
< Previous 1 2
...
24 25 26 27 28 29 30 31 32
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.